Plenary Session 4: Biologics and Novel Treatments for Allergic Disease

Monday, 8 December 2014: 10:30 - 12:00
Grand Ballroom (Sul America)
Chairpersons:   Mark Larché (Canada), Robert Lemanske (United States)
10:30 - 10:35
Welcoming Remarks
10:35 - 11:00
4-1PS: IL- 4 and IL-13 Blockade in Asthma | Andrew Wardlaw (United Kingdom)
11:00 - 11:25
4-2PS: Atopic Dermatitis: Cytokine Inhibition | Peter Schmid-Grendelmeier (Switzerland)
11:25 - 11:50
4-3PS: Omalizumab and Urticaria | Marcus Maurer (Germany)
11:50 - 12:00
Discussion
See more of: Plenary Sessions
<< Previous Session | Next Session >>